Is aflibercept an optimal treatment for wt RAS mCRC patients after progression to first line containing anti-EGFR?
Ruth Vera, Elena Mata, Encarnación González‐Flores, Ignacio Juez, Vicente Alonso, Patricia Iranzo, Nieves Martínez Lago, Carlos López, J Martin Cabrera, María José Safont, Ana Ruiz‐Casado, Mercedes Salgado, Beatríz González, P. Escudero, Fernando Rivera, Carles Pericay
Topics & Concepts
MedicineAfliberceptHepatologyInternal medicineOncologyColorectal cancerCancerChemotherapyBevacizumabColorectal Cancer Treatments and StudiesLung Cancer Treatments and MutationsRadiomics and Machine Learning in Medical Imaging